Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

SeraLab

SeraLab?uq=kzBhZRuG
1998 FOUNDED
M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of biologically manufactured components for drug development. The company controls and develops disease state matrices manufactured from human and animal blood, plasma and serum, used in drug discovery, compound development and clinical and research diagnostics, enabling scientists and biomedical researchers to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and the effects on disease processes.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Distributors/Wholesale
Other Industries
Biotechnology
Drug Discovery
Parent Company
Primary Office
  • 209, Tower Bridge Business Centre
  • 46-48 East Smithfield
  • London E1W 1AW
  • England

+44 01444 000000

SeraLab Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore SeraLab‘s full profile, request access.

Request full access to PitchBook

SeraLab Executive Team (1)

Name Title Board
Seat
Contact
Info
Jennifer Murray Founder